Coxsackie B-2 Antibody (Coxsackie B-2 Ab) is a specific immunoglobulin marker indicative of exposure to the Coxsackie B-2 virus, a member of the enterovirus family and one of the distinct serotypes within the Coxsackie B virus group. This serotype is known for its role in various clinical manifestations ranging from mild, flu-like symptoms to more severe conditions like myocarditis, pericarditis, and pancreatitis. The presence of Coxsackie B-2 antibodies, detectable through serological assays, is crucial in the diagnosis and epidemiological tracking of these infections. 

Coxsackie B-3 antibody (Coxsackie B-3 Ab) plays a pivotal role in the immunological response to Coxsackie B-3 virus, a significant member of the Enterovirus genus within the Picornaviridae family. This virus is known for its involvement in various clinical syndromes, ranging from mild gastrointestinal and respiratory illnesses to more severe conditions like myocarditis, pericarditis, and pancreatitis. The Coxsackie B-3 Ab is a specific antibody formed in response to infection by the Coxsackie B-3 virus, and its detection is crucial for the accurate diagnosis and epidemiological study of the virus.

Coxsackie B-4 antibody (Coxsackie B-4 Ab) is a specific immunoglobulin marker indicative of exposure to the Coxsackie B-4 virus, a member of the Enterovirus genus within the Picornaviridae family. This virus is known for its role in various human diseases, ranging from mild febrile illnesses to more severe conditions such as myocarditis, pancreatitis, and aseptic meningitis. The presence of Coxsackie B-4 Ab is particularly significant in the context of research into the etiology of type 1 diabetes mellitus; there is accumulating evidence suggesting that Coxsackie B-4 may act as a trigger in genetically predisposed individuals, potentially initiating or accelerating pancreatic beta-cell destruction.

Coxsackie B-5 Antibody (Coxsackie B-5 Ab) is a specific marker used in the serological diagnosis of infections caused by the Coxsackie B-5 virus, one of the several serotypes of the Coxsackie B viruses belonging to the Enterovirus genus. The presence of Coxsackie B-5 Ab in a patient's serum is indicative of an immune response to this particular serotype, which is known for its role in a range of acute and chronic illnesses.

Coxsackie B-6 Ab, or Coxsackie B-6 antibody, is a significant marker in the medical diagnosis and study of infections caused by the Coxsackie B-6 virus, a member of the Enterovirus genus within the Picornaviridae family. This specific antibody is part of the immune response to the Coxsackie B-6 virus, which is known for causing a spectrum of diseases, ranging from mild gastrointestinal distress to more severe conditions like myocarditis, pericarditis, and even pancreatitis. The presence of Coxsackie B-6 Ab in a patient's blood is indicative of either a current or past infection with this virus.

What is Coxsackie Virus – IgG?

Coxsackie viruses are a group of enteroviruses that can cause a variety of illnesses, ranging from mild to serious. These viruses are divided into Group A and Group B, each associated with different clinical conditions. Group A viruses often cause hand, foot, and mouth disease, while Group B viruses can lead to viral myocarditis, pericarditis, or aseptic meningitis.

The IgG antibody test for Coxsackie virus detects long-term immune response to the virus. IgG antibodies typically develop several weeks after infection and remain in the bloodstream for months or even years, indicating past exposure or infection.

What Does a Medium Result Mean?

A medium IgG result indicates a moderate level of antibodies, which may reflect:

• A recent past infection with declining antibody levels

• An incomplete or borderline immune response

• A nonspecific or cross-reactive finding, particularly in the absence of symptoms

This result should be interpreted alongside your clinical history, symptoms, and any corresponding IgM antibody results, which reflect current or recent infection.

Coxsackie-IgG Type A7 (IFT) detects long-lasting antibodies to Coxsackievirus A7 and is best viewed as evidence of past exposure, not proof of a current infection. Because IFT is assay-specific and enteroviruses can cross-react, use your lab’s cutoffs and clinical context. For suspected acute disease, pair serology with PCR/NAAT (throat/stool/CSF/lesion) and/or look for a fourfold rise in IgG on paired sera 2–4 weeks apart; IgM may support recent exposure but is less reliable than PCR for timing. In the absence of symptoms, elevated IgG usually needs no treatment. If symptomatic, care is typically supportive while ruling in/out other causes.

Coxsackie-IgG Type B1 (IFT) detects long-lasting antibodies to Coxsackievirus B1 and mainly indicates past exposure, not an active infection. Because IFT methods and cutoffs differ and cross-reactivity among enteroviruses can occur, rely on your lab’s ranges and your clinical picture. For suspected acute disease, pair serology with PCR/NAAT (throat/stool/CSF/lesion) and consider paired sera to look for a fourfold IgG rise over 2–4 weeks; IgM may suggest recent exposure but is less specific than PCR for timing. Coxsackie B viruses can involve the heart (myopericarditis), meninges, or pleura/pancreas—seek evaluation if symptoms fit. In the absence of symptoms, an elevated IgG usually needs no treatment.

The Crab marker measures IgG antibodies to proteins found in crab. Results are reported as none detected, very low, low, moderate, or high. These levels reflect immune exposure and recognition rather than a true shellfish allergy. Interpretation should consider symptom history, frequency of shellfish intake, and overall immune health.

Elevated antibody levels can be clinically significant — while the antibodies themselves don’t destroy anything, they do trigger an inflammatory response that can cause significant destruction of tissue and resulting symptoms. This response is not necessarily dependent on antibody levels. However, an equivocal result may mean you are just beginning to exhibit an immune reaction, so this is an important time to take measures to support the body in damping immune reactivity.

The Cranberry marker measures IgG antibodies to proteins found in cranberries. Results are reported as none detected, very low, low, moderate, or high. These levels reflect immune exposure and recognition rather than a true cranberry allergy. Interpretation should consider symptom history, preparation method, and overall dietary patterns.

The primary goal of a creatinine clearance test is to measure the estimated glomerular filtration rate (eGFR), providing insight into kidney filtration efficiency. It is instrumental in diagnosing, screening, and tracking the progression of kidney disease.

The test involves measuring creatinine levels in a blood sample and a 24-hour urine collection. Creatinine is a byproduct of the breakdown of creatine, which provides energy to muscles. The kidneys filter creatinine from the blood, and it is excreted in urine. By using a specific formula that considers creatinine levels in both the blood and urine, adjusted for body size, the test estimates the glomerular filtration rate (GFR).

A creatinine clearance test is performed to evaluate kidney function by analyzing both blood and urine samples. Creatinine is a waste product generated by normal muscle activity, which the kidneys filter from the blood and eliminate through urine. This test compares the levels of creatinine in the blood and urine to determine how effectively the kidneys are filtering blood, a key indicator for diagnosing and monitoring kidney health.

CK (creatine kinase), also called CPK (creatine phosphokinase), is an enzyme found in skeletal muscle, heart muscle, and brain tissue. The normal range is 24–204 U/L for most adults, but ranges differ by age and sex — men typically have higher CK levels than women. A low CK result often indicates reduced muscle mass, prolonged bed rest, or certain medical conditions. A high CK result indicates muscle damage from exercise, injury, medications (particularly statins), or disease. CK is always interpreted alongside clinical history and symptoms.

The CK-MB test measures levels of a specific enzyme, Creatine kinase-MB, primarily found in heart muscle cells, to diagnose heart damage. CK-MB is one of three forms of the creatine kinase enzyme, with the others being CK-MM and CK-BB, found in different muscles and organs. Elevated CK-MB levels, especially with a high ratio to total creatine kinase, indicate heart damage, which could be due to various causes such as physical trauma, surgery, or a heart attack. While historically crucial for diagnosing heart attacks, the CK-MB test has been largely replaced by more specific cardiac troponin tests. The test is performed mainly in emergency settings, with results varying based on individual health factors and laboratory standards.